检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵腾 赵翠 姜振宇[1] ZHAO Teng;ZHAO Cui;JIANG Zhenyu(Oncology Department Second Ward,Tengzhou Central People's Hospital,Tengzhou 277500,Shandong,China)
机构地区:[1]滕州市中心人民医院肿瘤科二病区,山东滕州277500
出 处:《中外医疗》2024年第24期75-77,82,共4页China & Foreign Medical Treatment
摘 要:目的 探究多西他赛+精确放疗同步化疗对食管癌患者的影响。方法 随机选取2020年1月—2023年8月滕州市中心人民医院肿瘤科二病区收治的80例食管癌患者为研究对象,根据不同治疗方法分为两组,均40例。对照组行精确放疗同步化疗,观察组在对照组基础上加多西他赛化疗。比较两组治疗效果、肿瘤标志物及治疗安全性。结果 观察组治疗总有效率为90.00%(36/40),高于对照组的70.00%(28/40),差异有统计学意义(χ^(2)=5.000,P<0.05)。治疗后,观察组的肿瘤标志物水平低于对照组,差异有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论 多西他赛联合精确放疗同步化疗可杀灭食管癌患者体内癌细胞,且无严重不良反应。Objective To explore the effect of docetaxel+precise radiotherapy concurrent chemotherapy on patients with esophageal cancer.Methods A total of 80 patients with esophageal cancer admitted to the Second Ward of Oncology Department of Tengzhou Central People's Hospital from January 2020 to August 2023 were randomly selected as the research objects.According to different treatment methods,they were divided into two groups,with 40 cases in each group.The control group was treated with precise radiotherapy and concurrent chemotherapy,and the observation group was treated with docetaxel chemotherapy on the basis of the control group.The therapeutic effect,tumor markers and treatment safety were compared between the two groups.Results The total effective rate of treatment in the observation group was 90.00%(36/40),which was higher than 70.00%(28/40)in the control group,and the difference was statistically significant(χ^(2)=5.000,P<0.05).After treatment,the level of tumor markers in the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Docetaxel combined with precise radiotherapy and concurrent chemotherapy can kill cancer cells in patients with esophageal cancer without serious adverse reactions.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.147